FREE WORLDWIDE SHIPPING FOR ORDERS FROM $99 
US: 2-3 WEEKS, 
EU: 1-2 WEEKS, 
REST OF WORLD: 1-4 WEEKS 
Nolpaza Enteric Tablets 40mg (14 Tablets): Effective Relief for Acid Reflux and Stomach Ulcers
Description:
Nolpaza enteric tablets contain pantoprazole sodium sesquihydrate, a proton pump inhibitor that effectively reduces stomach acid production. This medication is available in 40mg strength and comes in a pack of 14 tablets, providing convenient and reliable relief for various gastrointestinal conditions.
Indications:
Nolpaza 40mg tablets are indicated for the treatment of:
- Reflux Esophagitis: A condition where stomach acid flows back into the esophagus, causing irritation and pain.
- Peptic Ulcers: Open sores in the lining of the stomach or duodenum, often caused by H. pylori infection or NSAID use.
- Zollinger-Ellison Syndrome: A rare condition characterized by excessive stomach acid production.
- Eradication of H. pylori: A bacterium commonly associated with peptic ulcers. Nolpaza is used in combination with antibiotics for this purpose.
Important Information:
- Liver Function: Patients with severe liver impairment should be monitored closely during treatment, especially with prolonged use.
- NSAID Use: Limited doses of Nolpaza (20mg) should be used for the prevention of ulcers in patients requiring long-term NSAID therapy.
- Maligancy: If symptoms like unexplained weight loss, vomiting, or difficulty swallowing persist, a malignancy should be ruled out.
- Vitamin B12 Absorption: Pantoprazole can decrease vitamin B12 absorption. This is important for long-term users, especially those with low body weight or at risk of vitamin B12 deficiency.
- Hypomagnesemia: Severe hypomagnesemia has been reported in patients taking PPIs for extended periods. Monitor magnesium levels, especially in those with long-term therapy or using other medications that can cause hypomagnesemia.
- Fractures: Long-term high-dose PPI use may slightly increase the risk of hip, wrist, and spine fractures.
- Sorbitol: Nolpaza contains sorbitol. Patients with fructose intolerance should avoid this medication.
- Pediatric Use: Not recommended for children under 12 years of age.
- Pregnancy and Lactation: Avoid during pregnancy unless strictly necessary. Do not breastfeed while taking Nolpaza.
Dosage and Administration:
Nolpaza tablets should be swallowed whole with a small amount of liquid before meals. Consult your doctor for specific dosage instructions based on your condition and individual needs.
Possible Side Effects:
Nolpaza may cause side effects like headache, dizziness, diarrhea, nausea, vomiting, and rash. Consult your doctor if you experience any adverse reactions.
Where to Buy:
Purchase Nolpaza 40mg enteric tablets (14 tablets) from a trusted pharmacy or online retailer.
Disclaimer:
This information is for general knowledge and should not be used as a substitute for professional medical advice. Consult with your doctor before starting any new medication.
Keywords:
Nolpaza, pantoprazole, proton pump inhibitor, acid reflux, heartburn, GERD, esophagitis, peptic ulcer, Zollinger-Ellison syndrome, H. pylori, eradication, stomach acid, gastrointestinal, medication, tablets, dosage, side effects, buy online, pharmacy, health, digestive health, treatment, relief.
| INN | PANTOPRAZOLE |
|---|---|
| The code | 46 074 |
| Side effects | Uncommon (≥ 1/1, 000 to <1/100) sleep disturbances headache, dizziness diarrhea, nausea, vomiting, bloating and flatulence, constipation, dry mouth, abdominal pain, discomfort elevated liver enzymes (transaminases, γ-GT) rash, exanthema, skin rash, itching fractures of the bones of the spine, hip and wrist asthenia, malaise and fatigue Rarely (from ≥ 1/10, 000 to <1/1, 000) agranulocytosis hypersensitivity reactions (including anaphylactic reactions and anaphylactic shock) hyperlipidemia, increased levels of triglycerides, cholesterol, changes in body weight, taste disturbance depression (and all exacerbations) visual disturbances, blurred vision increased bilirubin levels urticaria, Quincke's edema arthralgia, myalgia gynecomastia fever, peripheral edema Very rarely (<1/ 10, 000) thrombocytopenia, leukopenia, confusion (and all associated exacerbations) Not known (cannot be estimated from the available data): hyponatremia, hypomagnesemia hallucinations inations, confusion (especially in genetically predisposed patients, and exacerbation of these symptoms if they existed before treatment) hepatocellular damage, jaundice, hepatocellular insufficiency Stevens-Johnson syndrome, Lyell's syndrome, erythema multiforme, photosensitivity interstitial nephritis |
| Importer | IOOO Interfarmaks 223028 Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Star, 19a-5, room. 5-2 |
| Composition Means | active substance – pantoprazole sodium sesquihydrate 22.55 mg or 45.10 mg (equivalent to pantoprazole 20 mg or 40 mg, respectively), excipients: mannitol, crospovidone (type B), anhydrous sodium carbonate, sorbitol (E420), calcium stearate, composition enteric coating: hypromellose (2.4-3.6 mPas), povidone (K25), titanium dioxide (E171), iron oxide yellow (E172), propylene glycol, *methacrylic acid-ethyl acrylate copolymer (1:1) 30% dispersion, macrogol 6000, talc |
| Main Active Substances | pantoprazole sodium sesquihydrate 22.55 mg or 45.10 mg |
| Release Form | tablets |
| Application Gender | Any |
| Use during pregnancy and lactation | unknown |
| Contraindications | hypersensitivity to pantoprazole, substituted benzimidazoles or auxiliary components of the drug – combined use with atazanavir |
| Barcode | 3, 84E+12 |
| Indications Applications | For a dosage of 20 mg: Adults and adolescents from 12 years of age and older – symptomatic gastroesophageal reflux disease – for the long-term treatment and prevention of relapse of reflux esophagitis. Adults – prevention of erosive and ulcerative lesions of the stomach and duodenum caused by the use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at increased risk and in need of ongoing treatment with NSAIDs (See section "special instructions") For a dosage of 40 mg Adults and adolescents from 12 years and older – reflux esophagitis Adults – eradication of Helicobacter pylori (H. pylori) in combination with appropriate antibiotic therapy in patients with peptic ulcer associated with H. pylori – peptic ulcer of the stomach and duodenum – Zollinger-Ellison syndrome and other pathological hypersecretory states |
| trade line | Nolpaza |
| Trademark | KRKA |
| Manufacturer | Krka dd, Slovenia |
| Active substance | Pantoprazole |
| Dosage | 40mg |
Related products
